Clinical, Haemodynamic and Neurohumoral Predictors of Poor Prognosis of Heart Failure with Preserved Ejection Fraction
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Patients with HFpEF who underwent meticulous clinical and instrumental evaluation (including diastolic stress test) between 2013 and 2020, will be followed up for at least 3 years.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:
• Signed and data informed consent;
• New York Heart Association (NYHA) class II-III heart failure;
• Left ventricular ejection fraction \> 50%;
• Increased LV filling pressures assessed at rest or at peak exercise by echocardiography.
Locations
Other Locations
Russian Federation
Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTRE OF CARDIOLOGY NAMED AFTER ACADEMICIAN E.I.CHAZOV. of the Ministry of Health of the Russian Federation
RECRUITING
Moscow
Contact Information
Primary
Artem G Ovchinnikov, MD, PhD, DSc
artcardio@mail.ru
+74954146612
Time Frame
Start Date: 2022-01-31
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 400
Treatments
with primary outcome
Patients with HFpEF who experienced primary outcome (were hospitalized for HF or died)
without primary outcome
Patients with HFpEF who survived without hospitalizations for HF
Related Therapeutic Areas
Sponsors
Leads: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation